Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
iShares Russell 3000 ETF
IWV
$20.6B
| $580K | ﹤0.01% |
3,367
+64
| +2% | +$10.8K |
|
4077
CALL
Healthpeak Properties
DOC
$14.4B
| $579K | ﹤0.01% |
22,000
-13,000
| -37% | -$342K |
|
4078
Editas Medicine
EDIT
$425M
| $579K | ﹤0.01% |
18,181
+3,994
| +28% | +$129K |
|
4079
Globant
GLOB
$1.66B
| $579K | ﹤0.01% |
9,828
+5,029
| +105% | +$295K |
|
4080
PUT
Lands' End
LE
$381M
| $579K | ﹤0.01% |
33,000
+13,900
| +73% | +$327K |
|
|
MRSH
4081
CALL
Marsh
MRSH
$89.7B
| $579K | ﹤0.01% |
7,000
-16,000
| -70% | -$1.36M |
|
|
NFX
4082
PUT
DELISTED
Newfield Exploration
NFX
| $579K | ﹤0.01% |
20,100
+300
| +2% | +$8.44K |
|
|
RETA
4083
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $578K | ﹤0.01% |
7,073
+5,905
| +506% | +$416K |
|
4084
CALL
Ryder
R
$10.2B
| $577K | ﹤0.01% |
7,900
-3,500
| -31% | -$267K |
|
4085
Sonic Automotive
SAH
$2.54B
| $577K | ﹤0.01% |
29,802
+14,562
| +96% | +$301K |
|
4086
CALL
Ameriprise Financial
AMP
$50.4B
| $576K | ﹤0.01% |
3,900
+400
| +11% | +$57.2K |
|
4087
Chesapeake Utilities
CPK
$3.26B
| $576K | ﹤0.01% |
6,863
+3,399
| +98% | +$289K |
|
4088
PUT
Shopify
SHOP
$199B
| $576K | ﹤0.01% |
35,000
-6,000
| -15% | -$91.4K |
|
4089
PUT
Strategic Education
STRA
$1.85B
| $576K | ﹤0.01% |
+4,200
| New | +$539K |
|
4090
PUT
UBS Group
UBS
$176B
| $576K | ﹤0.01% |
36,600
+600
| +2% | +$9.43K |
|
|
RNET
4091
DELISTED
RigNet, Inc.
RNET
| $576K | ﹤0.01% |
28,306
+24,007
| +558% | +$361K |
|
4092
PUT
AerCap
AER
$23.7B
| $575K | ﹤0.01% |
10,000
| – | – |
|
4093
Codexis
CDXS
$166M
| $575K | ﹤0.01% |
33,569
+28,314
| +539% | +$457K |
|
|
CTRA
4094
CALL
DELISTED
Coterra Energy
CTRA
| $574K | ﹤0.01% |
25,500
+10,100
| +66% | +$236K |
|
|
SOHU
4095
PUT
Sohu.com
SOHU
$363M
| $573K | ﹤0.01% |
28,800
+23,400
| +433% | +$594K |
|
4096
CALL
Copart
CPRT
$28.5B
| $572K | ﹤0.01% |
44,400
+32,400
| +270% | +$484K |
|
4097
PUT
Quest Diagnostics
DGX
$26B
| $572K | ﹤0.01% |
5,300
-2,900
| -35% | -$318K |
|
|
CORR
4098
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $571K | ﹤0.01% |
15,174
-4,153
| -21% | -$157K |
|
4099
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
| $570K | ﹤0.01% |
5,131
-13,345
| -72% | -$1.49M |
|
|
KANG
4100
DELISTED
iKang Healthcare Group, Inc.
KANG
| $570K | ﹤0.01% |
31,432
-104,906
| -77% | -$2.02M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.